Eric van der Putten

Chier Business Officer

Eric van der Putten is responsible for UPyTher’s strategic business development, partnerships and supporting the company’s growth activities. He brings more than 30 years of experience in clinical research, oncology drug development and biotech investment, providing valuable expertise in advancing innovative therapies from development to commercialization. His career includes leadership roles at specialized CROs such as NDDO Oncology, where he served as COO and CEO, followed by his appointment as Vice President of Oncology Europe at INC Research after its acquisition of NDDO. Eric later co-founded SMS-oncology, a specialized oncology CRO, and served as both COO and CEO. He is also a partner at Aglaia Oncology fund, founder of Modra Pharmaceuticals, and non-executive director at Mimetas. His extensive operational and commercial experience supports UPyTher’s growth and clinical development ambitions.